Improve Medical Instruments Co., Ltd. (300030) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Improve Medical Instruments Co., Ltd.

Why is Improve Medical Instruments Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 1.84%

The company has been able to generate a Return on Capital Employed (avg) of 1.84% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -6.24% and Operating profit at -194.68% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 3.41% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -6.24% and Operating profit at -194.68% over the last 5 years

Flat results in Jun 25

NET SALES(Q) At CNY 113.84 MM has Fallen at -16.98%
CASH AND EQV(HY) Lowest at CNY 302.86 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 0%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 19.19%, its profits have risen by 39.4%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Improve Medical Instruments Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Improve Medical Instruments Co., Ltd.

-100.0%

2.18

51.08%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-6.24%

EBIT Growth (5y)

-194.68%

EBIT to Interest (avg)

-1.98

Debt to EBITDA (avg)

2.96

Net Debt to Equity (avg)

0.15

Sales to Capital Employed (avg)

0.59

Tax Ratio

0.70%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.84%

ROE (avg)

3.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.10

EV to EBIT

-33.35

EV to EBITDA

-68.59

EV to Capital Employed

3.10

EV to Sales

3.75

PEG Ratio

Dividend Yield

ROCE (Latest)

-9.28%

ROE (Latest)

-7.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at 14.79 %

PRE-TAX PROFIT(Q)

At CNY 3.5 MM has Grown at 124.17%

NET PROFIT(Q)

At CNY 7.46 MM has Grown at 157.37%

RAW MATERIAL COST(Y)

Fallen by -6.28% (YoY

-13What is not working for the Company

NET SALES(Q)

At CNY 113.84 MM has Fallen at -16.98%

CASH AND EQV(HY)

Lowest at CNY 302.86 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0%

Here's what is working for Improve Medical Instruments Co., Ltd.

Pre-Tax Profit

At CNY 3.5 MM has Grown at 124.17%

over average net sales of the previous four periods of CNY -14.49 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 7.46 MM has Grown at 157.37%

over average net sales of the previous four periods of CNY -13 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 14.79 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -6.28% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Improve Medical Instruments Co., Ltd.

Net Sales

At CNY 113.84 MM has Fallen at -16.98%

over average net sales of the previous four periods of CNY 137.13 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Cash and Eqv

Lowest at CNY 302.86 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 0%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio